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UV radiation of the skin triggers keratinocytes to secrete endothelin-1 (ET-1) that binds to endothelin receptors
on neighboring melanocytes. Melanocytes respond with a prolonged increase in intracellular Ca2þ
concentration ([Ca2þ ]i), which is necessary for proliferation and melanogenesis. A major fraction of the
Ca2þ signal is caused by entry through Ca2þ -permeable channels of unknown identity in the plasma
membrane. ORAI Ca2þ channels are molecular determinants of Ca2þ release-activated Ca2þ (CRAC) channels
and are expressed in many tissues. Here, we show that ORAI1–3 and their activating partners stromal interaction
molecules 1 and 2 (STIM1 and STIM2) are expressed in human melanocytes. Although ORAI1 is the
predominant ORAI isoform, STIM2 mRNA expression exceeds STIM1. Inhibition of ORAI1 by 2-aminoethox-
ydiphenyl borate (2-APB) or downregulation of ORAI1 by small interfering RNA (siRNA) reduced Ca2þ entry and
CRAC current amplitudes in activated melanocytes. In addition, suppression of ORAI1 caused reduction in
the ET-1-induced cellular viability, melanin synthesis, and tyrosinase activity. Our results imply a role for
ORAI1 channels in skin pigmentation and their potential involvement in UV-induced stress responses of the
human skin.
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INTRODUCTION
Endothelin-1 (ET-1) and its two isoforms, endothelin-2 and
endothelin-3, exert their biological actions through engage-
ment of the two G-protein–coupled receptors, ET-A and
ET-B. ET-1 was first isolated from vascular endothelial cells
and characterized as a potent vasoconstrictor (Yanagisawa
et al., 1988). Besides its essential function in the cardio-
vascular system, a role for ET-1 has been described in
the physiology and pathophysiology of the renal, central
nervous, gastrointestinal, and immune systems (Rubanyi and
Polokoff, 1994; Levin, 1995; Watts, 2010). In the skin, ET-1 is
secreted from keratinocytes following their exposure to UV
radiation and affects neighboring melanocytes through
activation of their ET-B receptors (Yada et al., 1991; Imokawa
et al., 1992, 1995; Hirobe, 2011). Furthermore, it has
been suggested that ET-1 has anti-apoptotic effects and
reduces DNA damage in human melanocytes (Kadekaro
et al., 2005).
Activation of ET-B receptors leads to phospholipase
C–dependent formation of IP3 and diacylglycerol (Kang
et al., 1998; Slominski et al., 2004). IP3 triggers the IP3
receptors on the endoplasmic reticulum (ER) and causes
transient depletion of ER Ca2þ stores. Reduction in ER Ca2þ
is sensed by two ER-based proteins, stromal interaction
molecules 1 and 2 (STIM1 and STIM2) (Liou et al., 2005;
Zhang et al., 2005), that then oligomerize and translocate
toward the plasma membrane where they activate Ca2þ
release-activated Ca2þ (CRAC) channels encoded by the
ORAI genes (Feske et al., 2006; Vig et al., 2006; Zhang et al.,
2006). ORAI1 and its homologs ORAI2 and ORAI3 are highly
selective Ca2þ channels with cytosolic N- and C-termini and
four transmembrane segments. The signaling pathway lead-
ing to ORAI activation is also known as store-operated Ca2þ
entry (Parekh and Putney, 2005), whereas the ion current
conducted by CRAC/ORAI channels is known as ICRAC (Hoth
and Penner, 1992).
Concomitant production of diacylglycerol together with a
rise in [Ca2þ ]i activate protein kinases that via phosphoryla-
tion of Raf-1 activate mitogen-activated protein kinase
signaling pathways and CRE-binding protein-dependent
phosphorylation of microphthalmia-associated transcription
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factor and its subsequent upregulation (Imokawa et al., 2000;
Sato-Jin et al., 2008). Microphthalmia-associated transcrip-
tion factor regulates the expression of multiple genes
involved in melanogenesis and melanocyte survival such as
tyrosinase, TRP1 and 2, Bcl2, and CDK2 (Slominski et al.,
2004; Sato-Jin et al., 2008).
Changes in [Ca2þ ]i are thus important determinants for
proper melanocyte function (Schallreuter et al., 2008). High
[Ca2þ ]i is also required for active transport of L-phenylala-
nine into melanocytes by the calmodulin-dependent Ca2þ -
ATPase as well as for its turnover to L-tyrosine, an essential
signaling event in melanin synthesis (Schallreuter and Wood,
1999; Schallreuter et al., 2008). Furthermore, it has been
shown that melanin binds Ca2þ and thereby regulates the
redox state of melanocytes to prevent cell damage by
oxidative stress (Hoogduijn et al., 2004). In addition, ET-1-
induced phosphorylation of CRE-binding protein as well as
the scaffold protein kinase suppressor of Ras (KSR2) activa-
tion of ERK cascade are Ca2þ -dependent processes (Tada
et al., 2002; Dougherty et al., 2009). In pathophysiological
situations, increases in [Ca2þ ]i have been implicated in
melanoma growth and tumor invasion (Somlyo and Somlyo,
2003; Feldman et al., 2010; Arozarena et al., 2011).
Interestingly, before the discovery of STIM1 as a CRAC
channel activator, it was shown that STIM1 is upregulated in
metastatic melanomas and can serve as a metastatic marker
(Suyama et al., 2004).
Despite the established importance of Ca2þ for proper
melanocyte function, the molecular identity of the major
players involved in regulation of the Ca2þ homeostasis have
not been fully elucidated. More information is available on
Ca2þ homeostasis in melanoma cells (Schallreuter et al.,
1992; Nilius et al., 1993; Allen et al., 1997; Deli et al., 2007).
It has been proposed that TRP channels such as TRPM1 are
responsible for Ca2þ influx across the plasma membrane and
thus regulate melanin production in human melanocytes
(Devi et al., 2009; Oancea et al., 2009). However, TRPM1
channels are not store operated and will probably not be
activated by ET-1-induced IP3 production. At present, nothing
is known about the functional role of ORAI channels and
their activators STIM1 and 2 in human melanocytes.
RESULTS
To examine a potential role of ORAI channels in melano-
cytes, we analyzed [Ca2þ ]i following the application of
different stimuli. Melanocytes were exposed to nominally
Ca2þ -free bath solution and treated with 10 nM ET-1
(Figure 1a). This led to a rapid and transient increase in
[Ca2þ ]i, because of depletion of intracellular ER Ca
2þ stores.
Addition of Ca2þ to the external buffer after [Ca2þ ]i had
returned to basal levels caused a rapid influx of Ca2þ
(7.2±0.6 nMs–1), reaching an average maximal amplitude of
B612nM that then slowly declines. Similarly, addition of
1 mM thapsigargin to Ca2þ -free bath solution induced a
transient increase in [Ca2þ ]i because of nonreversible
inhibition of the sarco/ER Ca2þ -ATPases activity and a
subsequent more sustained external Ca2þ influx upon
Ca2þ addition (Figure 1b). The Ca2þ -influx rate was
7.04±1.4 nMs–1, resulting in an average maximal [Ca2þ ]i of
B540nM. To test a potential contribution of ORAI channels
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Figure 1. Characterization of melanocyte store-operated Ca2þ entry (SOCE) and ICRAC. (a) Endothelin-1 (ET-1; 10 nM)-induced [Ca
2þ ]i signals in
melanocytes without 2-aminoethoxydiphenyl borate (2-APB; black trace, n¼ 50) or with 50mM 2-APB (red, n¼ 74) in Ca2þ -free and 0.25mM Ca2þ -containing
external bath solution. CRAC, Ca2þ release-activated Ca2þ . (b) Intracellular [Ca2þ ]i in melanocytes before and after addition of 1 mM thapsigargin (Tg),
without 2-APB (black trace, n¼11) or with 50 mM 2-APB (red, n¼ 23) in Ca2þ -free and 0.25mM Ca2þ -containing external bath solution. (c) Average ICRAC
current densities (CDs) at –80mV in 10mM Ca2þ -containing external bath solution in primary human melanocytes. 2-APB (5 mM) was added 100 seconds
after break-in whereas 50mM 2-APB was added after 200 seconds (n¼ 9). Error bars indicate means±SEM. (d) Voltage/current (I/V) relationship in the
absence (green) or with 5mM 2-APB (red) or 50 mM 2-APB (black); n¼ 9.
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during Ca2þ influx, we applied 2-aminoethoxydiphenyl
borate (2-APB), an inhibitor of ORAI1 and ORAI2 channels.
As depicted in Figure 1a and b (red traces), 50 mM 2-APB
abolished both the ET-1 and the thapsigargin-induced
increase in [Ca2þ ]i, indicating a role of ORAI1 or ORAI2 in
ET-1-triggered melanocyte store-operated Ca2þ entry.
If ORAI1 or ORAI2 are involved in Ca2þ entry in
melanocytes, CRAC currents should be recordable. Using
the whole-cell patch-clamp configuration, we analyzed
currents following Ca2þ store depletion with 50 mM IP3 in
the patch pipette. As shown in Figure 1c, melanocytes
responded with rapidly activating inward currents that
reached a steady state of 0.61±0.12 pA/pF after 50 seconds.
In line with the known pharmacological properties of ICRAC,
current densities were facilitated by low (5 mM) 2-APB
concentrations and inhibited by 50 mM 2-APB (Prakriya and
Lewis, 2001). Furthermore, the current/voltage (I/V) relation-
ship showed typical inwardly rectifying properties as
expected of ICRAC (Figure 1d). To characterize the molecular
composition of CRAC channels in more detail, we evaluated
the relative expression levels of ORAI and STIM isoforms with
quantitative real-time PCR (Figure 2a). Cq values were
normalized to the reference gene TATA-binding protein
(TBP). Figure 2a shows that ORAI1 is the most abundant
ORAI isoform in melanocytes. Interestingly, STIM2 mRNA is
higher than STIM1, which corresponds with the finding that
cells originating from the neural crest express higher amounts
of STIM2 than STIM1 (Berna-Erro et al., 2009).
To test the contribution of ORAI1 in the ET-1-triggered
Ca2þ -influx, we used small interfering RNA (siRNA) against
ORAI1 (O1siRNA) to downregulate ORAI1 expression and
performed Ca2þ imaging experiments. ET-1 (10 nM) evoked
normal Ca2þ store release in control (CTRL) and O1siRNA-
treated melanocytes. However, the [Ca2þ ]i increase due to
Ca2þ entry across the plasma membrane was significantly
reduced in the cells treated with O1siRNA (Figure 2b, red
trace). CTRLsiRNA-transfected melanocytes show an average
maximal [Ca2þ ]i concentration of 634±30 nM, whereas
O1siRNA-treated cells peak at 213±9 nM (Po0.001). Be-
cause the initial slope of the rise in [Ca2þ ]i directly relates to
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Figure 2. Expression of ORAI1–3 and stromal interaction molecules 1 and 2 (STIM1–2) in melanocytes; ORAI1 downregulation. (a) Quantitative real-time
PCR (RT-PCR) analyses of ORAI1–3 and STIM1–2 expression normalized to TATA box-binding protein (TBP) in melanocytes from four healthy human
donors with different pigmentation (n¼ 6). (b) The effect of endothelin-1 (ET-1) on [Ca2þ ]i in melanocytes treated with control small interfering RNA
(CTRLsiRNA; black, n¼ 91) and O1siRNA (red, n¼98). (c) Ca2þ -influx rate calculated between 410 and 460 seconds from the traces shown in b.
Error bars indicate means±SEM. (d) Western blot analyses of ORAI1 expression in melanocytes treated with CTRL and O1siRNA at 24 and 48 hours after
transfection. (e, f) ORAI1 expression in melanocyte cytospins treated with CTRL or O1siRNA. Bar¼ 200mm. (g, h) Immunohistochemical staining of (g) ORAI1
and (h) melan-A in healthy human foreskin. Arrows indicate melanocytes in the basal epidermal layer. Bar¼ 50mm. GAPDH, glyceraldehyde-3-phosphate
dehydrogenase. ***Po 0.001.
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the activity of the influx channels, we analyzed the Ca2þ -
influx rate during the first 50 seconds following Ca2þ
addition and confirmed a highly significant 77% decrease
also in the Ca2þ -influx rate (Figure 2c). To verify the
efficiency of siRNA treatment, we performed western blot
analysis of cells transfected with CTRL and O1siRNA. Cells
were lysed 24 or 48 hours after transfection. Because ORAI1
is a complex glycosylated protein, it exists in several
molecular weight forms: a theoretical molecular weight of
32.7 kDa of the unmodified protein and two major glycosy-
lated proteins of B43 kDa and B50 kDa (Figure 2d, CTRL-
transfected cells). ORAI1 protein expression was strongly
reduced 24 and 48 hours after siRNA transfection, thus
confirming antibody specificity, with the control protein
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) not
being affected by the O1siRNA (Figure 2d). In addition, we
performed immunohistochemical analyses of primary mela-
nocytes transfected with either CTRL or O1siRNA, confirming
expression of ORAI1 and its successful downregulation by
siRNA treatment (Figure 2e and f). Furthermore, to examine
ORAI1 expression not only in cultured melanocytes but also
in vivo, we performed immunohistochemical analyses on
samples from healthy human foreskin (Figure 2g). The stains
indicate abundant presence of ORAI1 in melanocytes at the
basal epidermal layer as well as in all other epidermal
cells, confirming the finding that keratinocytes also express
ORAI1 (see McCarl et al., 2009). To verify the presence of
melanocytes in the basal epidermal layer, we stained for
melan-A in subsequent sections of the same foreskin sample
(Figure 2h).
Because ET-1 serves as a mitogenic and melanogenic
stimulus for melanocytes (Yada et al., 1991; Imokawa et al.,
1992, 1995), we investigated the potential role of ORAI1 in
melanocyte viability (metabolic activity). As the melanocyte
growth medium contains several mitogenic stimuli that could
interfere with determining the effect of ET-1 (see Table 1 and
Materials and Methods for details), we transferred melano-
cytes into three media with different or without supplementa-
tion (Table 1) for at least 48 hours before stimulation with
ET-1. Three concentrations of ET-1 (0.1, 1, and 10 nM) were
used and viability was determined at 3, 24, and 48 hours after
addition of ET-1. Figure 3a–c shows a clear concentration-
and time-dependent increase in viability in ET-1-stimulated
cells compared with control cells without ET-1 added to the
nonsupplemented medium (/). After 3 hours, no signifi-
cant change in viability was observed in cells exposed to
ET-1 (0.1–10 nM) in comparison with those without stimulus
(Figure 3a). However, after 24 hours with ET-1 stimulation,
1 and 10 nM ET-1-induced a 54 and 141% increase in
viability compared with nonstimulated cells (Figure 3b). After
48 hours, this effect becomes even more prominent with an
increase of 30% in 0.1 nM, 110% in 1 nM, and 257% in 10 nM
ET-1-stimulated cells (Figure 3c). The ET-1-induced increase
in viability is also observed in supplemented media, although
the effects are smaller (Supplementary Figure S1a-c online).
Given that ET-1 mediates Ca2þ -influx mainly through
ORAI1 channels, we determined the role of ORAI1 in this ET-
1-induced increase in viability. Melanocytes were transfected
with CTRL or O1siRNA, placed in (/) medium, and
stimulated as before (see Figure 3a–c). To isolate the effect of
ORAI1 on the ET-1-induced increase in viability, we first
calculated the percent change in viability of the O1siRNA-
treated cells compared with the ones treated with CTRLsiRNA
and then subtracted the background values obtained from
cells grown without ET-1 (Figure 3d–f). After 24 and 48 hours,
both CTRL and O1siRNA melanocytes showed increased
viability upon ET-1 treatment. However, the ET-1-induced
increase in viability was significantly lower in cells with
reduced levels of ORAI1 (Figure 3d–f). At 24 hours, the ET-1-
induced increase in viability was reduced by 83% (0.1 nM),
57% (1 nM), and 68% (10 nM) in O1siRNA-treated melano-
cytes versus CTRLsiRNA-treated ones (Figure 3e). After
48 hours, the reduction of the ET-1-induced increase in
viability was 92%, 72%, and 47%, respectively (Figure 3f).
These findings clearly indicate that ORAI1 plays a significant
role in the ET-1-induced melanocyte viability. In medium
with reduced supplements (/þ ), similar patterns between
CTRL and O1siRNA cells could be observed despite the
reduced effect of ET-1. In medium with complete supple-
mentation (þ /þ ), however, the effect of ET-1 on melanocyte
viability was almost negligible, thus not allowing evaluation
of the siRNA treatment (Supplementary Figure S1d-i online).
Because melanin production is one of the most important
physiological functions of melanocytes, we asked whether
the ET-1/ORAI1 pathway is involved in melanogenesis. To
avoid interference of other pro-melanotic compounds present
in the (þ /þ ) medium, cells were first kept in (/þ ) medium
for 7 days and for 2 subsequent days in (/) medium. Cells
were then stimulated with 10 nM ET-1 in the presence or
absence of 50 mM 2-APB. Melanin content was measured
after 48 hours and its concentration was calculated using
a calibration curve with known melanin concentrations.
Figure 4a shows that the basal melanin concentration in
nontreated cells was 20.7±1.13 pM per cell. Treatment with
2-APB alone did not induce significant changes in melanin
content. However, after 48 hours in the presence of 10 nM
Table 1. Differently supplemented growth media used in this study
M2 growth medium without supplement (/) Only medium
M2 growth medium with reduced supplements (/+) Medium+insulin+hydrocortisone+BFGF
M2 growth medium with complete supplements (+/+) Medium+insulin+hydrocortisone+BFGF+BPE+PMA
Insulin (5 mgml–1), hydrocortisone (0.5 mgml–1), basic fibroblast growth factor (BFGF; 1 ngml–1), bovine pituitary extract (BPE; 0.4%), and phorbol 12-
myristate 13-acetate (PMA; 175 nM).
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ET-1, the melanin concentration in melanocytes was sig-
nificantly increased to 26.5±3.2 pM per cell. This increase
was suppressed in cells that were additionally treated with
2-APB (Figure 4a). To further quantify the results shown in
Figure 4a, we calculated the percent of change in ET-1- and/
or 2-APB-treated cells and found that the ET-1-induced
increase in melanin concentration was 26.6±9.4% com-
pared with untreated cells (Figure 4b). However, augmented
melanin levels could be due to either increased synthesis or
decreased secretion. To address this, we performed measure-
ments of tyrosinase activity. Tyrosinase is one of the key
enzymes in the melanin biosynthetic pathway and its activity
is coupled with synthesis and not secretion. Melanocytes
were pretreated in the same manner as for melanin
measurements and were stimulated with ET-1 and/or 2-APB
for 6 hours. Figure 4c shows that ET-1 treatment induced
significantly higher tyrosinase activity (4.18±0.47 vs.
3.17±0.36U per 106 cells) that was blocked by ORAI1
inhibitor 2-APB (2.86±0.39U per 106 cells). Quantification
of the results in Figure 4c indicates that ET-1-induced a
32±4% increase in tyrosinase activity when compared with
controls. This increase is comparable to the increase in
melanin (26.6%).
In summary, our findings suggest that Ca2þ influx con-
trolled by ORAI1 channels not only mediates the mitogenic
effects of ET-1, but is also involved in the regulation of ET-1-
regulated melanogenesis in human melanocytes.
DISCUSSION
Our results show that ORAI1 channels are one of the major
Ca2þ -entry pathways in primary human melanocytes. The
expression pattern of the three ORAI isoforms and their
activators STIM1 and STIM2 revealed that ORAI1 and STIM2
transcripts are most abundant. High relative expression of
STIM2 may reflect the neural origins of melanocytes;
however, relative expression of ORAI1 compared with ORAI2
is relatively low in neuronal cells, but high in melanocytes.
STIM2 has lower affinity for Ca2þ than STIM1 and may
thus increase basal [Ca2þ ]i. In addition, because of the
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slower oligomerization of STIM2 upon ER Ca2þ store
depletion, cells expressing higher amounts of STIM2 should
display lower but prolonged increases in [Ca2þ ]i (Berna-Erro
et al., 2009). Interestingly, this seems not to be the
case in melanocytes despite their high STIM2 content as
thapsigargin- and ET-1-induced store-operated Ca2þ entry is
rapid and large but returns to basal levels after relatively short
time periods (Figures 1a and b). A possible explanation for
these differences may be cellular morphology, size, and
location of ER and mitochondria and/or the role of other
STIM-regulated Ca2þ -permeating channels such as TRPCs
and/or voltage-gated Ca2þ channels (CaV) (Worley et al.,
2007; Park et al., 2010; Wang et al., 2010). Further studies
are needed to examine not only the role of STIM2
in melanocytes, but also the functional significance of
different ORAI/TRPC/CaV/STIM expression ratios in different
skin cell types.
This study assigns an important physiological role for
ORAI1 in ET-1-regulated melanocyte function. Measure-
ments of cellular viability and melanogenesis suggest that
proper melanocyte function strongly depends on ORAI1.
Because ET-1 is produced by keratinocytes upon UV light
exposure, our results propose that ORAI1 may be involved in
the process of ‘‘adaptive tanning’’ rather than in the
regulation of basal skin pigmentation. A defective ORAI1-
dependent Ca2þ entry in melanocytes may thus lead to
impaired tanning ability.
Following UV radiation, keratinocytes and melanocytes,
in addition to ET-1, also secret corticotropin-releasing
hormone, which serves as a paracrine signal and leads to
increase in the local levels of proopiomelanocortin-derived
peptides such as ACTH, a-melanocyte-stimulating hormone,
and endorphin (Slominski et al., 2000; Zbytek et al., 2006).
Notably, corticotropin-releasing hormone as well as ACTH
also induce IP3 production and increase in [Ca
2þ ]i (Fazal
et al., 1998; Wiesner et al., 2003; Slominski et al., 2006),
raising the distinct possibility that ORAI1-mediated Ca2þ
influx could also be involved in the regulation of cellular
functions controlled by these peptides, in particular under
stress conditions such as UV radiation.
In mice lacking either ORAI1 or STIM1, skin pathologies
such as hair loss or dermatitis have been reported
(Gwack et al., 2008; Oh-hora et al., 2008). Furthermore,
in very few human patients with nonfunctional CRAC
channels due to mutations in ORAI1 and STIM1 genes
(severe combined immunodeficiency patients), ectodermal
dysplasia with anhydrosis, but no detectable pigmentation
defects, was observed (McCarl et al., 2009; Picard et al.,
2009). However, it is unknown whether UV-induced skin
tanning is affected in these patients. A comparison of
adaptive tanning in humans with defective ORAI and/or
STIM function with healthy controls could provide further
evidence for the role of ET-1 and Ca2þ signaling in
melanocyte function.
Our results also suggest that prolonged activation or
upregulation of ORAI1 and STIM proteins could play a role in
pigmentary disorders and even skin cancer. This assumption
is supported by reports that show that defects in ET-1
signaling cascade are connected with tumor progression
and metastasis in melanoma (Demunter et al., 2001; Lahav
et al., 2004; Spinella et al., 2007) and also by reports showing
upregulation of ORAI and STIM proteins in cancer growth,
migration, and metastasis (Suyama et al., 2004; Yang et al.,
2009; Feng et al., 2010; Motiani et al., 2010; Prevarskaya
et al., 2011). Considering these findings, it is possible
that ORAI channels may also be involved in pathophysio-
logical melanocyte activity and in skin cancer growth and
metastasis.
MATERIALS AND METHODS
Chemicals
All chemicals were purchased from Sigma if not otherwise indicated.
Cells
Cells were isolated from neonatal foreskins of healthy individuals
provided by the Department of Urology, University of Saarland, with
a parental consent. To establish a monoculture of human dermal
melanocytes, the isolated cell mix was cultivated in M2 growth
medium (Promocell, Heidelberg, Germany) at 37 1C, 5% CO2, and
95% humidity. Keratinocytes and fibroblasts do not grow in this
medium and were thus lost during cell culture. For most
experiments, growth medium with different supplements was used
(see Table 1). The study adhered to the Declaration of Helsinki
Principles and was approved by the local ethics committee.
siRNA transfection
A total of 1.5 106 cells were transfected with the same O1siRNA or
CTRLsiRNA (20 mM) as in Bogeski et al. (2010) using nucleofector
technology (Lonza, Cologne, Germany) following the manufacturer’s
instructions.
Fluorescence-based Ca2þ imaging
[Ca2þ ]i was determined using 1 mM Fura-2-acetoxymethyl ester, as
described in Bogeski et al. (2010). The images were analyzed using
TILL Vision software (TILL Vision, Munich, Germany). The absolute
intracellular Ca2þ concentration was calculated according to
Grynkiewicz et al. (1985).
Electrophysiology
Recordings were performed at room temperature in the tight-seal
whole-cell configuration. Patch pipettes had a final resistance of
2–3MO and were coated with Sigmacote. Pipette and cell
capacitance were electronically compensated before each voltage
ramp with an EPC-10 patch-clamp amplifier controlled by Patch-
master software (HEKA, Lambrecht, Germany). Immediately after
establishing whole-cell configuration, linear voltage ramps from
150mV to þ 150mV of 50ms duration were applied every
2 seconds from a holding potential of 0mV for the indicated time
period. Membrane currents were sampled at 10 kHz and filtered at
2.9 kHz. For leak current correction, the ramp current before current
activation was subtracted. Voltages were corrected for a liquid
junction potential of 10mV. The pipette solution contained
(in mM): 120 cesium-glutamate, 3 MgCl2, 20 cesium-Bapta, 10
Hepes, and 0.05 IP3 (pH 7.2 with CsOH). The bath solution
contained (in mM): 120 NaCl, 10 TEA-Cl, 2 MgCl2, 10 Hepes, and
glucose (pH 7.2 with NaOH).
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Cell viability and proliferation
Measurements were carried out in black 96-well cell culture plates
with transparent bottom (BD, Heidelberg, Germany). Each data point
was measured in triplicates. Melanocytes (3,000 per well) were
seeded in a total volume of 200ml growth medium and incubated at
37 1C, 5% CO2, and 95% humidity. After 48 hours in the different
growth media (see Table 1), untransfected as well as siRNA-
transfected cells were stimulated with 0.1, 1, and 10 nM ET-1 or
buffer (control stimulus). Cell viability was analyzed after 3, 24, and
48 hours with CellTiter-Blue assay (Promega, Mannheim, Germany).
Because of the different initial values in each growth medium,
viability of melanocytes without ET-1 (control) was always taken as
100%. The effect of ET-1 stimulation was calculated as percentage of
control. To isolate the effect of O1siRNA treatment on ET-1-induced
increase in viability, 100% (control, no ET-1) were subtracted from
all values with ET-1 stimulation.
Quantitative real-time PCR
Total RNA was isolated from 1 106 melanocytes from four donors.
Then, 1 mg of total RNA was used for reverse transcription, and 0.5 ml
complementary DNA and 300 nM primer were used with a Quanti
Tect SYBR green kit (Qiagen, Hilden, Germany). PCR conditions
were: 15 minutes, 94 1C; 45 cycles, 30 seconds at 94 1C; 45 seconds
at 58 1C; 30 seconds at 72 1C; with a final cycle (60 seconds at 95 1C;
30 seconds at 55 1C; and 30 seconds at 95 1C) using the MX3000_
cycler (Stratagene, Waldbronn, Germany). Expression ofORAI1-3 and
STIM1-2 was normalized to the reference gene TBP (#NM_003194).
Relative expression was calculated according to the DCq method
(2DCq). Cq values were determined by the MX3000 software. Follow-
ing primers were used: STIM1_forw_50-CAGAGTCTGCATGACCTT
CA-30, STIM1_rev_50-GCTTCCTGCTTAGCAAGGTT-30, STIM2_forw_
50-GTCTCCATTCCACCCTATCC-30, STIM2_rev_50-GGCTAATGATC
CAGGAGGTT-30, Orai1_forw_50-ATGAGCCTCAACGAGCACT-30
Orai1_rev_50-GTGGGTAGTCGTGGTCAG-30 Orai2_forw_50-TGGA
ACTGGTCACCTCTAAC-30 Orai2_rev_50-GGGTACTGGTACTGCGT
CT-30, Orai3_forw_50-GTACCGGGAGTTCGTGCA-30, Orai3_rev_
50-GGTACTCGTGGTCACTCT-30, TBP_forw_50-CGGAGAGTTCTGG
GATTGT-30, TBP_rev_50-GGTTCGTGGCTCTCTTATC-30.
Immunoblotting
A total of 50 mg protein was separated by 15% SDS-PAGE and trans-
ferred onto nitrocellulose membranes. Anti-Orai1 antibody (2mgml–1,
O8264, Sigma) incubations were performed at 4 1C overnight, and blots
were washed 3 with Tris-buffered saline and Tween 20. Secondary
antibody goat anti-rabbit 1:1,000 was applied for 1hour at room
temperature. Blot was washed 3 with Tris-buffered saline and Tween
20. Bands were detected with Lumi-Light substrate (Roche Diagnostics,
Mannheim, Germany). To assess equal loading, blots were stripped and
reprobed with anti-GAPDH antibody.
Immunohistochemistry
Sections from paraffin-embedded foreskins were deparafinated and
pretreated with heat-induced epitope retrieval solution (Dako
Cytomation target-retrieval solution, pH 6), while cultured melano-
cytes (5 105) were attached on a coverslip using a cytospin
centrifuge (Thermo Type Cytospin 4, Thermo Fisher Scientific,
Schwerte, Germany). Samples were stained with 20mgml–1 anti-
ORAI1 (O8264, Sigma) or anti-Melan-A (clone A103, M7196;
dilution 1:100; Dako, Hamburg Germany) using Dako Autostainer
Plus and Dako REAL detection system, with alkaline phosphatase/
RED-conjugated anti-rabbit, anti-mouse antibody (K5005). Sections
were examined by light microscopy.
Melanin measurements
Cells were grown in (/þ ) medium for 7 days and transferred in
(/) medium for additional 2 days. Following this treatment, cells
were stimulated with 10nM ET-1 in the presence or absence of 50mM
2-APB. Untreated cells (no ET-1) were used as control. After 48hours,
cells were washed twice, harvested by trypsinization, counted, and
lysed in phosphate-buffered saline with 1% Triton X-100 for
30minutes at 4 1C. Approximately 1 106 cells were used per
condition. The lysate was than centrifuged at 14,000g for 40minutes
at 4 1C. The remaining pellet was dissolved in 200ml 1N NaOH at
85 1C for 60minutes. To determine the melanin content, absorbance
was measured at 465nm with a reference at 630nm. Absolute
melanin content was calculated by using a melanin calibration curve
obtained by dissolving concentrations of synthetic melanin in 200ml
1N NaOH. Melanin concentration was normalized to cell number.
Tyrosinase activity
Melanocytes were pretreated similarly as for melanin measurements and
stimulated for 6hours. 2-APB was always applied 5minutes before ET-1.
Cells were lysed in 200ml phosphate-buffered saline with 1% Triton
X-100 for 30minutes at 4 1C and centrifuged at 14000g for 30minutes at
4 1C. Then, 50ml of the supernatant was mixed with phosphate-buffered
saline with or without 1mM L-DOPA to a final volume of 200ml per well.
Formation of L-DOPAchrome was recorded by measuring absorbance
at 465nm with a reference at 630nm after 45minutes at 37 1C.
The samples without L-DOPA were taken as background and were
subtracted from the measured value. Tyrosinase activity was calculated
from a calibration curve obtained from known mushroom tyrosinase
(Sigma, T3824) concentrations and was normalized to cell number.
Data analysis and statistics
Data were analyzed using TILL Vision (TILL Photonics), Fitmaster
2.35 (HEKA) Igor Pro (Wavemetrics, Portland, OR), and Microsoft
Excel (Microsoft). Data are mean±SEM, and asterisks indicate
significance: *Po0.05, **Po0.01, and ***Po0.001 (unpaired
and/or paired two-sided Student’s t-test). For each condition, at
least three experiments were performed from at least two different
donors.
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Figure S1
Figure S1. The role of ORAI1 in ET-1-induced melanocyte viability in differentially supplemented 
growth media
(a-c) Relative melanocyte viability in (-/+) and (+/+) growth medium, 3h (a), 24h (b) and 48h (c) following 
stimulation with 0.1, 1 and 10 nM ET-1; n=5. Results are presented as % of control (100%, without ET-1). 
(d-i) Change in the ET-1-induced increase in viability of melanocytes treated with O1siRNA (d-f) and 
CTRLsiRNA (g-i) in (-/+) and (+/+) growth medium, 3h (d), 24h (e) and 48h (f) following stimulation with 
0.1, 1 and 10 nM ET-1; n=7. Measurements with ET-1 were evaluated as % of control (100%, without ET-
1). To isolate the effect of ORAI1 on ET-1-induced increase in viability, 100% (value without ET-1) was 
subtracted from all values in panel d-i. Error bars indicate means ± SEM.
